Tapi Czech Industries S.R.O.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Oct 7, 2027The maintenance fee for Solid state forms of obeticholic acid salts (US 10,611,793) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,220,488 | Crystalline Polymorph of Ponesimod In force · High confidence | In force | High confidence | |
| US 10,611,793 | Solid state forms of obeticholic acid salts In force · From the USPTO record | In force | From the USPTO record | |
| US 12,534,448 | Solid State Form of Lemborexant In force · High confidence | In force | High confidence | |
| US 12,735,391 | Polymorphs of Ponesimod In force · High confidence | In force | High confidence | |
| US 12,637,446 | Solid State Forms of Asciminib and Processes for the Preparation Thereof In force · High confidence | In force | High confidence | |
| US 12,637,459 | Solid State Forms of Lorecivivint In force · High confidence | In force | High confidence |
Also on record, not counted in the 6: 1 patent in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.